Langerhans cells and hematologic status of children with reticular dysgenesis
Patient (reference) . | Skin sample . | Langerhans cells . | Allogeneic BMT . | Graft versus host disease . |
---|---|---|---|---|
1 (19) | Fixed | 0 | 0 | 0 |
2 (24, BE) | Fixed | 0 | 0 | + |
3 (24, JE) | Fixed | 0 | 0 | + |
3 (24, JE) | Fixed | 0 | 0 | + |
4 (24, CB) | Fixed | 0 | Yes* | 0 |
5 (11) | Frozen | 0 | 0 | 0 |
5 (11) | Frozen | 0 | Day 7 | 0 |
6 (29) | Fixed | + | Day 15 | + |
7 (31) | Both | + | Day >700 | 0 |
Patient (reference) . | Skin sample . | Langerhans cells . | Allogeneic BMT . | Graft versus host disease . |
---|---|---|---|---|
1 (19) | Fixed | 0 | 0 | 0 |
2 (24, BE) | Fixed | 0 | 0 | + |
3 (24, JE) | Fixed | 0 | 0 | + |
3 (24, JE) | Fixed | 0 | 0 | + |
4 (24, CB) | Fixed | 0 | Yes* | 0 |
5 (11) | Frozen | 0 | 0 | 0 |
5 (11) | Frozen | 0 | Day 7 | 0 |
6 (29) | Fixed | + | Day 15 | + |
7 (31) | Both | + | Day >700 | 0 |
At the time of skin biopsy, this patient had undergone 3 consecutive, unsuccessful allogeneic bone marrow transplantations.